✦ LIBER ✦

Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan

✍ Scribed by Fumitaka Suzuki; Yasuji Arase; Norio Akuta; Akihito Tsubota; Yoshiyuki Suzuki; Hitomi Sezaki; Tetsuya Hosaka; Takashi Someya; Masahiro Kobayashi; Satoshi Saitoh; Kenji Ikeda; Mariko Kobayashi; Marie Matsuda; Junko Satoh; Hiromitsu Kumada

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 146 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-004-1430-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of interferon monotherapy in yo

Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection

✍ Kiminori Uka; Fumitaka Suzuki; Norio Akuta; Hitomi Sezaki; Yoshiyuki Suzuki; Tet 📂 Article 📅 2006 🏛 Springer Japan 🌐 English ⚖ 171 KB

Lymphoblastoid interferon in controlled

Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection

✍ Stephanos J. Hadziyannis 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Long-term beneficial effect of interfero

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

✍ Shi-Ming Lin; I-Shyan Sheen; Rong-Nan Chien; Chia-Ming Chu; Yun-Fan Liaw 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5

Efficacy of lamivudine therapy in elderl

Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection

✍ Tomokazu Kawaoka; Fumitaka Suzuki; Norio Akuta; Yoshiyuki Suzuki; Yasuji Arase; 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 202 KB

Autoantibody prevalence in chronic hepat

Autoantibody prevalence in chronic hepatitis B virus infection: Effect in interferon alfa

✍ G V Gregorio; H Jones; K Choudhuri; A Vegnente; F Bortolotti; G Mieli-Vergani; D 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

albeit with different prevalences, and a third report suggests The most effective treatment of chronic hepatitis B that IFN-a may be a trigger for autoimmune hepatitis. 13 To virus (HBV) infection is interferon alfa (IFN-a), a potenaddress the question as to whether any clinical or serological tiall

Loss of HBsAg with interferon-α therapy

Loss of HBsAg with interferon-α therapy in chronic hepatitis D virus infection

✍ Johnson Y. N. Lau; Ruth King; Christopher J. Tibbs; Adrian P. Catterall; Heather 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

Eleven patients with chronic hepatitis D virus (HDV) infection who had chronic active hepatitis and HDV antigen on liver biopsy were randomised in a crossover therapeutic trial of interferon-alpha 2b vs. no therapy. Nine patients had a history of intravenous drug use (drug free > 6 months before the